Home / Peptide legality / Oregon
Are peptides legal in Oregon?
Peptides sit in a legal gray zone in Oregon, where FDA-approved medicines such as Wegovy® (semaglutide) are legal with a valid prescription while unapproved research peptides such as BPC-157 have no lawful compounding pathway, and the Oregon Board of Pharmacy has issued a formal position statement on GLP-1 compounding.
Legal status overview
Peptides sit in a gray zone in Oregon. The state has no peptide-specific statute, so access is governed by the federal Food, Drug, and Cosmetic Act, FDA compounding rules under sections 503A and 503B, and the Oregon Board of Pharmacy, which issued a Semaglutide Position Statement (version 2/2025) on GLP-1 compounding. FDA-approved GLP-1 receptor agonist medicines such as Ozempic® (semaglutide) and Zepbound® (tirzepatide) are legal when prescribed by a licensed clinician, while unapproved research peptides such as BPC-157 and TB-500 cannot be lawfully compounded or sold for human use. Compounded medications are not FDA-approved, are not a generic, and have not been evaluated by the FDA.
Key points
- Oregon has no peptide-specific law; peptide access follows the federal FDA framework layered over Oregon Board of Pharmacy licensing and position statements. [2]
- The Oregon Board of Pharmacy Semaglutide Position Statement (version 2/2025) warns that compounding or dispensing GLP-1 products in a way that fails to conform with governing law may lead to Board enforcement action. [1]
- Oregon requires that any semaglutide base used for compounding be a pharmaceutical-grade product with a valid certificate of analysis from an FDA-registered establishment, and research-use-only material may never be used for compounding. [1]
- BPC-157 remains in Category 2 of the FDA interim 503A bulks list, so licensed Oregon 503A compounding pharmacies may not compound it for any patient or indication. [6]
- FDA-approved GLP-1 receptor agonist medicines are legal by prescription in Oregon when ordered by a licensed clinician subject to Oregon Medical Board prescribing rules. [3]
- After the FDA declared the GLP-1 shortage resolved, compounding drug products that are essentially copies of approved GLP-1 medicines is generally not permitted absent a documented patient-specific clinical need. [5]
- Growth hormone (somatropin) is an FDA-approved prescription drug, and federal law makes distributing it for non-approved uses such as anti-aging or bodybuilding a criminal offense. [7]
- Compounded medications, including compounded semaglutide, are not FDA-approved, are not a generic, and have not been evaluated by the FDA. [5]
Compound-by-compound status
| BPC-157 Restricted | Unapproved drug with no USP or NF monograph; sits in Category 2 of the FDA interim 503A bulks list, so it cannot be lawfully compounded or sold for human use in Oregon. |
|---|---|
| GLP-1 receptor agonist class (Wegovy® (semaglutide), Ozempic® (semaglutide), Zepbound® (tirzepatide), Mounjaro® (tirzepatide)) Legal | FDA-approved brands are legal by prescription; the Oregon Board of Pharmacy restricts compounded versions through its position statement, and compounded semaglutide is not FDA-approved, not a generic, and not evaluated by the FDA. |
| TB-500 (thymosin beta-4) Restricted | Unapproved drug that does not appear on the FDA 503A bulks list; not lawful to compound or to sell for human use in Oregon. |
| Growth hormone / somatropin Restricted | FDA-approved prescription drug limited to specific medical indications; federal law criminalizes distribution for non-approved uses such as anti-aging, athletic performance, or bodybuilding. |
Frequently asked questions
Are peptides legal in Oregon?
It depends on the peptide. FDA-approved medicines such as Wegovy® (semaglutide) are legal with a valid prescription, while unapproved research peptides such as BPC-157 and TB-500 have no lawful pathway for human use. This is information, not medical or legal advice.
What does the Oregon Board of Pharmacy say about compounded semaglutide?
The Board issued a Semaglutide Position Statement (version 2/2025) warning that non-conforming compounding or dispensing may trigger enforcement, requiring pharmaceutical-grade API with a certificate of analysis from an FDA-registered establishment, and barring research-use-only material.
Can an Oregon pharmacy compound BPC-157?
No. BPC-157 is an unapproved drug in Category 2 of the FDA interim 503A bulks list, so licensed Oregon compounding pharmacies may not compound it.
Is compounded semaglutide the same as Wegovy® or Ozempic®?
No. Compounded semaglutide is not FDA-approved, is not a generic, and has not been evaluated by the FDA, unlike the approved brands Wegovy® (semaglutide) and Ozempic® (semaglutide).
Is growth hormone legal in Oregon?
Somatropin is an FDA-approved prescription drug for specific medical conditions. Federal law makes distributing it for non-approved uses such as anti-aging or bodybuilding a crime.
Sources
- Oregon Board of Pharmacy: Semaglutide Position Statement v.2/2025 (retrieved 2026-09-21)
- Oregon Board of Pharmacy: Position Statements (retrieved 2026-09-21)
- Oregon Medical Board: Prescribing, Topics of Interest (retrieved 2026-09-21)
- FDA: Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act (retrieved 2026-09-21)
- FDA: Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize (retrieved 2026-09-21)
- Holt Law: BPC-157 in 2026, Why Regulatory Limbo Is Not the Same as a Green Light (retrieved 2026-09-21)
- DEA Diversion Control Division: Human Growth Hormone (retrieved 2026-09-21)
Last researched: 2026-09-21.
More from Peptides.io
- GLP-1 Treatment Gap Index →Our analysis of where Medicaid access to GLP-1s falls shortest, by state
- The Gray-Market Peptide Report →Our analysis of how unapproved peptides are sold and marketed
- Original research from Peptides.io →Data reports we produce ourselves
Peptide legality in other states
All 50 states are covered. These are the next few alphabetically.
- Pennsylvanialegal gray zone
- Rhode Islandlegal gray zone
- South Carolinastate adds its own limits
- South Dakotalegal gray zone
- Tennesseelegal gray zone
FDA recalls from firms in Oregon
Firms with the most records
Most recent
| Firm | City | Class | Initiated | Reason given |
|---|---|---|---|---|
| PAYLESS COMPOUNDERS, LLC | Beaverton | Class II | 2026-03-06 | Lack of Assurance of Sterility |
| Hiers Enterprises, LLC dba Northwest Compounding Pharmacy | Roseburg | Class II | 2019-01-02 | Lack of sterility assurance. |
| Oregon Compounding Centers, Inc. dba Creative Compounds | Wilsonville | Class II | 2014-10-06 | Lack of Sterility Assurance: All lots of sterile products compounded b |
A recall here means the FDA recorded a product being withdrawn by a firm with an address in Oregon. Most involve compounded preparations and the most common reason given is a lack of assurance of sterility. It describes enforcement history, not whether a product is legal to buy in Oregon. Source: openFDA drug enforcement reports, checked 2026-11-10.